{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:26:20Z","timestamp":1747178780393,"version":"3.40.5"},"reference-count":94,"publisher":"Informa UK Limited","issue":"14","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,9,22]]},"DOI":"10.1080\/14656566.2022.2128757","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T07:46:54Z","timestamp":1664178414000},"page":"1651-1665","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-960X","authenticated-orcid":false,"given":"D.","family":"Santagata","sequence":"first","affiliation":[{"name":"Department of Medicine and Surgery, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Varese and Como, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-1627","authenticated-orcid":false,"given":"G.","family":"Camm\u00e0","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Curore, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-318X","authenticated-orcid":false,"given":"M.P.","family":"Donadini","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Varese and Como, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5705-2897","authenticated-orcid":false,"given":"A.","family":"Squizzato","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Varese and Como, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-8879","authenticated-orcid":false,"given":"W.","family":"Ageno","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Varese and Como, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"issue":"4","key":"cit0001","first-page":"750","volume":"94","author":"Cohen AT","year":"2005","journal-title":"Thromb Haemost"},{"doi-asserted-by":"publisher","key":"cit0002","DOI":"10.7326\/0003-4819-146-4-200702200-00007"},{"doi-asserted-by":"publisher","key":"cit0003","DOI":"10.3390\/jcm8122039"},{"doi-asserted-by":"publisher","key":"cit0004","DOI":"10.1136\/jcp.2003.013581"},{"doi-asserted-by":"publisher","key":"cit0005","DOI":"10.1016\/S0140-6736(08)60202-0"},{"issue":"1","key":"cit0006","first-page":"64","volume":"91","author":"Samama MM","year":"2006","journal-title":"Haematologica"},{"doi-asserted-by":"publisher","key":"cit0007","DOI":"10.1111\/j.1538-7836.2006.01818.x"},{"doi-asserted-by":"publisher","key":"cit0008","DOI":"10.1056\/NEJMoa041533"},{"doi-asserted-by":"publisher","key":"cit0009","DOI":"10.1160\/TH08-05-0337"},{"doi-asserted-by":"publisher","key":"cit0010","DOI":"10.1111\/j.1538-7836.2010.04044.x"},{"doi-asserted-by":"publisher","key":"cit0011","DOI":"10.1378\/chest.10-1944"},{"doi-asserted-by":"publisher","key":"cit0012","DOI":"10.1056\/NEJM199909093411103"},{"doi-asserted-by":"publisher","key":"cit0013","DOI":"10.1161\/01.CIR.0000138928.83266.24"},{"doi-asserted-by":"publisher","key":"cit0014","DOI":"10.1136\/bmj.38733.466748.7C"},{"doi-asserted-by":"publisher","key":"cit0015","DOI":"10.1378\/chest.11-2302"},{"doi-asserted-by":"publisher","key":"cit0016","DOI":"10.1182\/bloodadvances.2018022954"},{"doi-asserted-by":"publisher","key":"cit0017","DOI":"10.1371\/journal.pone.0234957"},{"doi-asserted-by":"publisher","key":"cit0018","DOI":"10.1160\/TH16-01-0003"},{"doi-asserted-by":"publisher","key":"cit0019","DOI":"10.7326\/0003-4819-153-1-201007060-00004"},{"issue":"20","key":"cit0020","first-page":"1945","volume":"368","author":"Cohen AT","year":"2013","journal-title":"N Engl J Med"},{"doi-asserted-by":"publisher","key":"cit0021","DOI":"10.1056\/NEJMoa1110899"},{"doi-asserted-by":"publisher","key":"cit0022","DOI":"10.1056\/NEJMoa1805090"},{"doi-asserted-by":"publisher","key":"cit0023","DOI":"10.1056\/NEJMoa1601747"},{"doi-asserted-by":"publisher","key":"cit0024","DOI":"10.1016\/S0140-6736(21)02392-8"},{"doi-asserted-by":"publisher","key":"cit0025","DOI":"10.1111\/jth.15126"},{"doi-asserted-by":"publisher","key":"cit0026","DOI":"10.2165\/00003495-199549030-00006"},{"unstructured":"Information NCfB. PubChem compound summary for CID 772, enoxaparin. 2022 [cited 2022 Mar 22]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Enoxaparin","key":"cit0027"},{"doi-asserted-by":"publisher","key":"cit0028","DOI":"10.1016\/S0049-3848(03)00030-6"},{"unstructured":"Information NCfB. PubChem compound summary for CID 5282448, Fondaparinux. [cited 2022 March 22].","key":"cit0029"},{"unstructured":"Information NCfB. PubChem compound summary for CID 10182969, Apixaban. 2022 [cited 2022 Mar 22]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Apixaban","key":"cit0030"},{"unstructured":"Information NCfB. PubChem compound summary for CID 9875401, Rivaroxaban. 2022 cited 2022 Mar 22. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Rivaroxaban","key":"cit0031"},{"unstructured":"Information NCfB. PubChem compound summary for CID 10275777, Betrixaban. 2022 cited 2022 Mar 22. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Betrixaban","key":"cit0032"},{"doi-asserted-by":"publisher","key":"cit0033","DOI":"10.1177\/106002809502900912"},{"unstructured":"Bevyxxa FDA. (betrixaban) prescribing information. 2018 [cited 2022 Mar 22]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020164s116lbl.pdf","key":"cit0034"},{"doi-asserted-by":"publisher","key":"cit0035","DOI":"10.2174\/138955707780363819"},{"doi-asserted-by":"publisher","key":"cit0036","DOI":"10.5858\/2006-130-1605-EOFOCA"},{"issue":"3","key":"cit0037","first-page":"261","volume":"43","author":"Babin JL","year":"2017","journal-title":"Semin Thromb Hemost"},{"doi-asserted-by":"publisher","key":"cit0038","DOI":"10.2146\/ajhp070624"},{"doi-asserted-by":"publisher","key":"cit0039","DOI":"10.1016\/j.bmcl.2009.02.111"},{"doi-asserted-by":"publisher","key":"cit0040","DOI":"10.1007\/s11239-011-0551-3"},{"doi-asserted-by":"publisher","key":"cit0041","DOI":"10.1345\/aph.1Q119"},{"key":"cit0042","first-page":"343","volume":"11","author":"Chan NC","year":"2015","journal-title":"Vasc Health Risk Manag"},{"doi-asserted-by":"publisher","key":"cit0043","DOI":"10.1111\/jth.13486"},{"doi-asserted-by":"publisher","key":"cit0044","DOI":"10.1007\/s00228-005-0043-5"},{"doi-asserted-by":"publisher","key":"cit0045","DOI":"10.1111\/j.1365-2125.2012.04369.x"},{"doi-asserted-by":"publisher","key":"cit0046","DOI":"10.1177\/1076029619847524"},{"doi-asserted-by":"publisher","key":"cit0047","DOI":"10.2165\/00003088-200342120-00003"},{"doi-asserted-by":"publisher","key":"cit0048","DOI":"10.1097\/00007691-200406000-00015"},{"doi-asserted-by":"publisher","key":"cit0049","DOI":"10.1016\/S0049-3848(02)00031-2"},{"doi-asserted-by":"publisher","key":"cit0050","DOI":"10.2165\/00003495-200565070-00009"},{"doi-asserted-by":"publisher","key":"cit0051","DOI":"10.1111\/j.0960-135X.2005.01452.x"},{"doi-asserted-by":"publisher","key":"cit0052","DOI":"10.1378\/chest.11-2291"},{"unstructured":"Eliquis FDA. (apixaban), prescribing information. 2012 cited 2022 Mar 22. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/202155s000lbl.pdf","key":"cit0053"},{"doi-asserted-by":"publisher","key":"cit0054","DOI":"10.1016\/j.clpt.2005.06.011"},{"doi-asserted-by":"publisher","key":"cit0055","DOI":"10.1592\/phco.29.2.167"},{"doi-asserted-by":"publisher","key":"cit0056","DOI":"10.2165\/0003088-200948010-00001"},{"doi-asserted-by":"publisher","key":"cit0057","DOI":"10.1124\/dmd.108.023143"},{"doi-asserted-by":"publisher","key":"cit0058","DOI":"10.1002\/prp2.603"},{"doi-asserted-by":"publisher","key":"cit0059","DOI":"10.1093\/eurheartj\/suy016"},{"doi-asserted-by":"publisher","key":"cit0060","DOI":"10.1007\/s40262-012-0030-9"},{"doi-asserted-by":"publisher","key":"cit0061","DOI":"10.1007\/s40262-013-0100-7"},{"key":"cit0062","first-page":"905","author":"Kubitza DB","year":"2006","journal-title":"Annu Meet Am Soc Hematol Blood"},{"doi-asserted-by":"publisher","key":"cit0063","DOI":"10.2217\/fca.13.98"},{"doi-asserted-by":"publisher","key":"cit0064","DOI":"10.1517\/13543784.2013.825605"},{"doi-asserted-by":"publisher","key":"cit0065","DOI":"10.1007\/s40262-020-00879-x"},{"doi-asserted-by":"publisher","key":"cit0066","DOI":"10.1016\/j.blre.2017.02.001"},{"doi-asserted-by":"publisher","key":"cit0067","DOI":"10.1056\/NEJMoa1111288"},{"doi-asserted-by":"publisher","key":"cit0068","DOI":"10.1177\/1358863X19898253"},{"unstructured":"Raritan NJUS, Approves FDA. XARELTO\u00ae (rivaroxaban) to help prevent blood clots in acutely Ill medical patients 2019 cited 2022 Mar 22. Available from: https:\/\/www.jnj.com\/u-s-fda-approves-xarelto-rivaroxaban-to-help-prevent-blood-clots-in-acutely-ill-medical-patients","key":"cit0069"},{"unstructured":"Raritan NJ. FDA approved betrixaban (BEVYXXA, Portola) for the prophylaxis of venous thromboembolism (VTE) in adult patients. 2019 [cited 2022 March 22]. Available from: https:\/\/www.jnj.com\/u-s-fda-approves-xarelto-rivaroxaban-to-help-prevent-blood-clots-in-acutely-ill-medical-patients#:~:text=RARITAN%2C%20N.J.%2C%20October%2014%2C,medical%20patients%20at%20risk%20for","key":"cit0070"},{"unstructured":"E.M.A. Refusal of the marketing authorisation for Dexxience (betrixaban). 2018 [cited 2022 Mar 22]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/smop-initial\/questions-answers-refusal-marketing-authorisation-dexxience-betrixaban_en.pdf","key":"cit0071"},{"doi-asserted-by":"publisher","key":"cit0072","DOI":"10.1177\/1358863X18818319"},{"doi-asserted-by":"publisher","key":"cit0073","DOI":"10.1007\/s11239-019-01878-x"},{"doi-asserted-by":"publisher","key":"cit0074","DOI":"10.1007\/s11239-016-1461-1"},{"doi-asserted-by":"publisher","key":"cit0075","DOI":"10.1177\/1076029619886022"},{"doi-asserted-by":"publisher","key":"cit0076","DOI":"10.1055\/s-0040-1705137"},{"doi-asserted-by":"publisher","key":"cit0077","DOI":"10.1055\/s-0037-1603929"},{"doi-asserted-by":"publisher","key":"cit0078","DOI":"10.1177\/1076029619850897"},{"doi-asserted-by":"publisher","key":"cit0079","DOI":"10.1016\/j.blre.2018.04.001"},{"doi-asserted-by":"publisher","key":"cit0080","DOI":"10.1161\/ATVBAHA.118.312130"},{"key":"cit0081","first-page":"149","volume":"68","author":"Ratnoff OD","year":"1955","journal-title":"Trans Assoc Am Physicians"},{"doi-asserted-by":"publisher","key":"cit0082","DOI":"10.1111\/bjh.13058"},{"doi-asserted-by":"publisher","key":"cit0083","DOI":"10.1038\/s41573-020-0061-0"},{"doi-asserted-by":"publisher","key":"cit0084","DOI":"10.4155\/ppa-2020-0002"},{"doi-asserted-by":"publisher","key":"cit0085","DOI":"10.1056\/NEJMoa1405760"},{"doi-asserted-by":"publisher","key":"cit0086","DOI":"10.1161\/ATVBAHA.113.301282"},{"doi-asserted-by":"publisher","key":"cit0087","DOI":"10.1001\/jama.2019.20687"},{"doi-asserted-by":"publisher","key":"cit0088","DOI":"10.1056\/NEJMoa2105872"},{"doi-asserted-by":"publisher","key":"cit0089","DOI":"10.1056\/NEJMoa2113194"},{"doi-asserted-by":"publisher","key":"cit0090","DOI":"10.1021\/acs.jmedchem.1c00613"},{"doi-asserted-by":"publisher","key":"cit0091","DOI":"10.1111\/jth.15588"},{"doi-asserted-by":"publisher","key":"cit0092","DOI":"10.3389\/fcvm.2022.903029"},{"doi-asserted-by":"publisher","key":"cit0093","DOI":"10.1111\/j.1365-2516.2006.01304.x"},{"doi-asserted-by":"publisher","key":"cit0094","DOI":"10.1111\/jth.15579"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2128757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T12:14:29Z","timestamp":1666786469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2128757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":94,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,9,22]]}},"alternative-id":["10.1080\/14656566.2022.2128757"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2128757","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"type":"print","value":"1465-6566"},{"type":"electronic","value":"1744-7666"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}